Position in APGE
as of Jun 30, 2026
· filed Aug 25, 2026
Position Value
$11,158,876
New position
Shares Held
84,072
first reported quarter
Ownership
0.111%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#83
of 288 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Groupe la Francaise holds $13,850,146 across 9 Biotechnology names. APGE ranks #1 (80.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
This page
|
84,072 | $11,158,876 | |
| 2 | RNA |
Atrium Therapeutics, Inc.
|
80,273 | $1,079,671 | |
| 3 | TBPH |
Theravance Biopharma, Inc.
|
30,000 | $510,000 | |
| 4 | BNTX |
BioNTech SE
|
4,200 | $390,810 | |
| 5 | MRNA |
Moderna, Inc.
|
5,053 | $353,861 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
553 | $344,817 | |
| 7 | RPRX |
Royalty Pharma plc
|
216 | $12,111 | |
| 8 | 256,497 | $0 |
All Filings in APGE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,158,876 | 84,072 | Shares | Defined | 2026-08-25 | |
| No filing history on record for this holder in this stock. | ||||||